196 related articles for article (PubMed ID: 7914720)
21. Determination of the effects of mycophenolic acid on the nucleotide pool of human peripheral blood mononuclear cells in vitro by high-performance liquid chromatography.
Daxecker H; Raab M; Cichna M; Markl P; Müller MM
Clin Chim Acta; 2001 Aug; 310(1):81-7. PubMed ID: 11485759
[TBL] [Abstract][Full Text] [Related]
22. Biochemical differences among four inosinate dehydrogenase inhibitors, mycophenolic acid, ribavirin, tiazofurin, and selenazofurin, studied in mouse lymphoma cell culture.
Lee HJ; Pawlak K; Nguyen BT; Robins RK; Sadée W
Cancer Res; 1985 Nov; 45(11 Pt 1):5512-20. PubMed ID: 2865005
[TBL] [Abstract][Full Text] [Related]
23. Determination of inosine monophosphate dehydrogenase activity in human CD4+ cells isolated from whole blood during mycophenolic acid therapy.
Vethe NT; Bergan S
Ther Drug Monit; 2006 Oct; 28(5):608-13. PubMed ID: 17038874
[TBL] [Abstract][Full Text] [Related]
24. IMP-dehydrogenase inhibition in human lymphocytes and lymphoblasts by mycophenolic acid and mycophenolic acid glucuronide.
Griesmacher A; Weigel G; Seebacher G; Müller MM
Clin Chem; 1997 Dec; 43(12):2312-7. PubMed ID: 9439448
[TBL] [Abstract][Full Text] [Related]
25. Biochemical effect of three different inhibitors of purine/pyrimidine metabolism on differentiation in HL60 cells.
Ahmed N; Weidemann MJ
Leuk Res; 1995 Apr; 19(4):263-73. PubMed ID: 7538618
[TBL] [Abstract][Full Text] [Related]
26. Species-specific inhibition of inosine 5'-monophosphate dehydrogenase by mycophenolic acid.
Digits JA; Hedstrom L
Biochemistry; 1999 Nov; 38(46):15388-97. PubMed ID: 10563825
[TBL] [Abstract][Full Text] [Related]
27. Molecular mechanisms of new immunosuppressants.
Halloran PF
Clin Transplant; 1996 Feb; 10(1 Pt 2):118-23. PubMed ID: 8680047
[TBL] [Abstract][Full Text] [Related]
28. Structure-activity relationships for inhibition of inosine monophosphate dehydrogenase and differentiation induction of K562 cells among the mycophenolic acid derivatives.
Mitsuhashi S; Takenaka J; Iwamori K; Nakajima N; Ubukata M
Bioorg Med Chem; 2010 Nov; 18(22):8106-11. PubMed ID: 20934342
[TBL] [Abstract][Full Text] [Related]
29. Inosine monophosphate dehydrogenase (IMPDH) inhibition in vitro suppresses lymphocyte proliferation and the production of immunoglobulins, autoantibodies and cytokines in splenocytes from MRLlpr/lpr mice.
Jonsson CA; Carlsten H
Clin Exp Immunol; 2001 Jun; 124(3):486-91. PubMed ID: 11472413
[TBL] [Abstract][Full Text] [Related]
30. E. coli gpt gene expression effects on K562 human leukemia cell proliferation and erythroid differentiation altered by mycophenolic acid.
Kamano H; Tanaka T; Yamaji Y; Ikeda K; Hata Y; Shiotani T; Ishida T; Takahara J; Irino S
Biochem Int; 1992 Mar; 26(3):537-43. PubMed ID: 1627163
[TBL] [Abstract][Full Text] [Related]
31. Biological effects of inhibition of guanine nucleotide synthesis by mycophenolic acid in cultured neuroblastoma cells.
Cass CE; Lowe JK; Manchak JM; Henderson JF
Cancer Res; 1977 Sep; 37(9):3314-20. PubMed ID: 195725
[TBL] [Abstract][Full Text] [Related]
32. Cell differentiation and altered IMP dehydrogenase expression induced in human T-lymphoblastoid leukemia cells by mycophenolic acid and tiazofurin.
Kiguchi K; Collart FR; Henning-Chubb C; Huberman E
Exp Cell Res; 1990 Mar; 187(1):47-53. PubMed ID: 1967583
[TBL] [Abstract][Full Text] [Related]
33. Influence of mycophenolic acid on inosine 5'-monophosphate dehydrogenase activity in human peripheral blood mononuclear cells.
Daxecker H; Raab M; Müller MM
Clin Chim Acta; 2002 Apr; 318(1-2):71-7. PubMed ID: 11880114
[TBL] [Abstract][Full Text] [Related]
34. An inosine 5'-monophosphate dehydrogenase 2 single-nucleotide polymorphism impairs the effect of mycophenolic acid.
Winnicki W; Weigel G; Sunder-Plassmann G; Bajari T; Winter B; Herkner H; Sengoelge G
Pharmacogenomics J; 2010 Feb; 10(1):70-6. PubMed ID: 19770842
[TBL] [Abstract][Full Text] [Related]
35. Mycophenolate mofetil and its mechanisms of action.
Allison AC; Eugui EM
Immunopharmacology; 2000 May; 47(2-3):85-118. PubMed ID: 10878285
[TBL] [Abstract][Full Text] [Related]
36. Regulation of inosine monophosphate dehydrogenase type I and type II isoforms in human lymphocytes.
Jain J; Almquist SJ; Ford PJ; Shlyakhter D; Wang Y; Nimmesgern E; Germann UA
Biochem Pharmacol; 2004 Feb; 67(4):767-76. PubMed ID: 14757177
[TBL] [Abstract][Full Text] [Related]
37. Effects of the inhibitors of IMP dehydrogenase, tiazofurin and mycophenolic acid, on glycoprotein metabolism.
Sokoloski JA; Sartorelli AC
Mol Pharmacol; 1985 Dec; 28(6):567-73. PubMed ID: 2867464
[TBL] [Abstract][Full Text] [Related]
38. A biochemical basis for synergism of 6-mercaptopurine and mycophenolic acid in Molt F4, a human malignant T-lymphoblastic cell line.
Stet EH; De Abreu RA; Janssen YP; Bökkerink JP; Trijbels FJ
Biochim Biophys Acta; 1993 Jan; 1180(3):277-82. PubMed ID: 8422434
[TBL] [Abstract][Full Text] [Related]
39. Relationships between the cytotoxicity of tiazofurin and its metabolism by cultured human lung cancer cells.
Carney DN; Ahluwalia GS; Jayaram HN; Cooney DA; Johns DG
J Clin Invest; 1985 Jan; 75(1):175-82. PubMed ID: 2856924
[TBL] [Abstract][Full Text] [Related]
40. Tight links between adenine and guanine nucleotide pools in mouse pancreatic islets: a study with mycophenolic acid.
Detimary P; Xiao C; Henquin JC
Biochem J; 1997 Jun; 324 ( Pt 2)(Pt 2):467-71. PubMed ID: 9182705
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]